Sigma Planning Corp’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $764K | Buy |
7,113
+508
| +8% | +$54.6K | 0.02% | 605 |
|
2025
Q1 | $666K | Sell |
6,605
-873
| -12% | -$88.1K | 0.02% | 625 |
|
2024
Q4 | $668K | Sell |
7,478
-422
| -5% | -$37.7K | 0.02% | 625 |
|
2024
Q3 | $662K | Buy |
7,900
+389
| +5% | +$32.6K | 0.02% | 639 |
|
2024
Q2 | $578K | Sell |
7,511
-2,496
| -25% | -$192K | 0.02% | 673 |
|
2024
Q1 | $685K | Buy |
10,007
+6,016
| +151% | +$412K | 0.02% | 641 |
|
2023
Q4 | $231K | Sell |
3,991
-6,222
| -61% | -$360K | 0.02% | 721 |
|
2023
Q3 | $539K | Buy |
10,213
+746
| +8% | +$39.4K | 0.02% | 684 |
|
2023
Q2 | $512K | Buy |
9,467
+73
| +0.8% | +$3.95K | 0.02% | 727 |
|
2023
Q1 | $470K | Buy |
9,394
+613
| +7% | +$30.7K | 0.02% | 824 |
|
2022
Q4 | $406K | Sell |
8,781
-16
| -0.2% | -$740 | 0.01% | 850 |
|
2022
Q3 | $341K | Buy |
8,797
+761
| +9% | +$29.5K | 0.01% | 892 |
|
2022
Q2 | $300K | Buy |
8,036
+395
| +5% | +$14.7K | 0.01% | 984 |
|
2022
Q1 | $338K | Buy |
7,641
+139
| +2% | +$6.15K | 0.01% | 996 |
|
2021
Q4 | $319K | Buy |
7,502
+416
| +6% | +$17.7K | 0.01% | 1040 |
|
2021
Q3 | $307K | Buy |
+7,086
| New | +$307K | 0.01% | 1041 |
|